The MonarchE trial: improving the clinical outcome in HR+/HER2− early breast cancer: recent results and next steps

• François Bertucci,
• Pascal Finetti,
• Emilie Mamessier,
• Alexandre De Nonneville

Affiliations

François Bertucci

Laboratory of Predictive Oncology Cancer Research Center of Marseille Paoli‐Calmettes Institute Aix‐Marseille University, INSERM UMR1068, CNRS UMR725, Team Labelled “Ligue contre le cancer” MarseilleFrance

Pascal Finetti

Laboratory of Predictive Oncology Cancer Research Center of Marseille Paoli‐Calmettes Institute Aix‐Marseille University, INSERM UMR1068, CNRS UMR725, Team Labelled “Ligue contre le cancer” MarseilleFrance

Emilie Mamessier

Laboratory of Predictive Oncology Cancer Research Center of Marseille Paoli‐Calmettes Institute Aix‐Marseille University, INSERM UMR1068, CNRS UMR725, Team Labelled “Ligue contre le cancer” MarseilleFrance

Alexandre De Nonneville

Laboratory of Predictive Oncology Cancer Research Center of Marseille Paoli‐Calmettes Institute Aix‐Marseille University, INSERM UMR1068, CNRS UMR725, Team Labelled “Ligue contre le cancer” MarseilleFrance